Skip to content
2000
Volume 6, Issue 3
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Mpox is a zoonotic disease caused by the orthopox virus, and its signs and symptoms are similar to those of smallpox in humans. As public health organizations try to end the present epidemic, healthcare professionals across the globe place a high premium on their education on the many clinical symptoms and possible treatments for this virus. For those who are affected, there is currently no cure. However, due to the smallpox outbreak, specialists are now looking at vaccinia immune globulin (IVG), tecovirimat, and cidofovir as potential remedies for Mpox. In severe cases, tecovirimat and supportive care may be used with drugs to aid with symptom alleviation. The World Health Organization (WHO) reports that the EMA acknowledged tecovirimat as a secure and reliable therapy for Mpox in 2023. The effectiveness of these therapies is fiercely contested since there are clear guidelines for decreasing these symptoms. Moreover, by examining elements such as the quantity of confirmed, probable, and possible cases, the median age at presentation, the fatality rate, and the geographic distribution of the disease, we hoped to understand the epidemiology of Mpox better as it was changing throughout this study. In light of recent widespread outbreaks, this page provides an updated analysis of Mpox and the medical remedies that are now accessible.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/covid/10.2174/0126667975301557240604113752
2024-06-13
2025-09-27

  • From This Site

    /content/journals/covid/10.2174/0126667975301557240604113752
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. IslamM.A. MuminJ. HaqueM.M. Monkeypox virus (MPXV): A Brief account of global spread, epidemiology, virology, clinical features, pathogenesis, and therapeutic interventions.Infect. Med.20232426227210.1016/j.imj.2023.11.001 38205182
     [Google Scholar]
  2. KumarP. ChaudharyB. YadavN. Recent advances in research and management of human monkeypox virus: An emerging global health threat.Viruses202315493710.3390/v15040937 37112916
     [Google Scholar]
  3. ShehryarA. Halappa NagarajR. KanwalF. Unraveling Monkeypox: An emerging threat in global health.Cureus2023158e4396110.7759/cureus.43961 37753017
     [Google Scholar]
  4. RanaS. NegiP. DeviM. ButolaM. AnsoriA.N.M. JakhmolaV. Systematic review on new face of monkeypox virus.J. Pure Appl. Microbiol.202216Suppl. 13119312910.22207/JPAM.16.SPL1.07
     [Google Scholar]
  5. StefanoJ.S. SilvaL.R.G. KalinkeC. Human monkeypox virus: Detection methods and perspectives for diagnostics.TrAC Trends Anal Chem20232023117226
     [Google Scholar]
  6. RabaanA.A. Al-ShwaikhS.A. AlfouzanW.A. A comprehensive review on monkeypox viral disease with potential diagnostics and therapeutic options.Biomedicines2023117182610.3390/biomedicines11071826 37509466
     [Google Scholar]
  7. SinghR. RaoJ.D.P. JhaA. JashwantS. SinghV.K. Post Covid Opportunities.Probecell Press2023
     [Google Scholar]
  8. SardanaK. SachdevaS. NarulaS. GogateS. Triaging cases of fever with vesicular rash relevant to the monkeypox epidemic.Trop. Doct.202353448148810.1177/00494755231185616 37403493
     [Google Scholar]
  9. FarlowA. TorreeleE. GrayG. The future of epidemic and pandemic vaccines to serve global public health needs.Vaccines202311369010.3390/vaccines11030690 36992275
     [Google Scholar]
  10. SayarshadH.R. Interventions in demand and supply sides for vaccine supply chain: An analysis on monkeypox vaccine.Operat ResPerspect20231110028510.1016/j.orp.2023.100285
     [Google Scholar]
  11. DobhalK. GhildiyalP. AnsoriA.N.M. JakhmolaV. An international outburst of new form of monkeypox virus.J. Pure Appl. Microbiol.202216Suppl. 13013302410.22207/JPAM.16.SPL1.01
     [Google Scholar]
  12. PachauriS. PachauriA. Global Perspectives of COVID-19 Pandemic on Health, Education, and Role of Media.Springer Nature202310.1007/978‑981‑99‑1106‑6
     [Google Scholar]
  13. KhameesA. AwadiS. Al-ShamiK. Human monkeypox virus in the shadow of the COVID-19 pandemic.J. Infect. Public Health20231681149115710.1016/j.jiph.2023.05.013 37269693
     [Google Scholar]
  14. KhattakS. RaufM.A. AliY. The monkeypox diagnosis, treatments and prevention: A review.Front. Cell. Infect. Microbiol.202312108847110.3389/fcimb.2022.1088471 36814644
     [Google Scholar]
  15. SrivastavaS. KumarS. JainS. The global monkeypox (Mpox) Outbreak: A comprehensive review.Vaccines2023116109310.3390/vaccines11061093 37376482
     [Google Scholar]
  16. LetafatiA. SakhavarzT. Monkeypox virus: A review.Microb. Pathog.202317610602710.1016/j.micpath.2023.106027 36758824
     [Google Scholar]
  17. EthawiY. Mohammed KhederR. HuseynovaR. SrijanS. AhmadD. Monkeypox Infection, what we need to Know About.J Pediatr Neonatal Biol202383226232
     [Google Scholar]
  18. GhoshB. The Virus Touch: Theorizing Epidemic Media.Duke University Press2023
     [Google Scholar]
  19. FalendyszE.A. LoperaJ.G. RockeT.E. OsorioJ.E. Monkeypox Virus in animals: Current knowledge of viral transmission and pathogenesis in wild animal reservoirs and captive animal models.Viruses202315490510.3390/v15040905 37112885
     [Google Scholar]
  20. KumarS. GuruparanD. KaruppananK. Recent Advances in Monkeypox (Mpox): Characterization, diagnosis, and therapeutics: A multidimensional review.Authorea202310.22541/au.168846306.66701439/v1
     [Google Scholar]
  21. EspositoM.M. TurkuS. LehrfieldL. ShomanA. The impact of human activities on zoonotic infection transmissions.Animals20231310164610.3390/ani13101646 37238075
     [Google Scholar]
  22. RajakarunaR.S. EremeevaM.E. Eco‐epidemiology of tick‐borne pathogens: Role of tick vectors and host animal community composition in their circulation and source of infections.In: One Heal Human, Anim Environ Triad.Wiley Online Library202332535010.1002/9781119867333.ch23
     [Google Scholar]
  23. Martínez-FernándezD.E. Fernández-QuezadaD. Casillas-MuñozF.A.G. Human monkeypox: A comprehensive overview of epidemiology, pathogenesis, diagnosis, treatment, and prevention strategies.Pathogens202312794710.3390/pathogens12070947 37513794
     [Google Scholar]
  24. BegumJ.P.S. NgangomL. SemwalP. PainuliS. SharmaR. GuptaA. Emergence of monkeypox: A worldwide public health crisis.Hum. Cell202336387789310.1007/s13577‑023‑00870‑1 36749539
     [Google Scholar]
  25. IslamM.M. DuttaP. RashidR. Pathogenicity and virulence of monkeypox at the human-animal-ecology interface.Virulence2023141218635710.1080/21505594.2023.2186357 36864002
     [Google Scholar]
  26. RabaanA.A. AbasA.H. TalleiT.E. Monkeypox outbreak 2022: What we know so far and its potential drug targets and management strategies.J. Med. Virol.2023951e2830610.1002/jmv.28306 36372558
     [Google Scholar]
  27. NiuL. LiangD. LingQ. Insights into monkeypox pathophysiology, global prevalence, clinical manifestation and treatments.Front. Immunol.202314113225010.3389/fimmu.2023.1132250 37026012
     [Google Scholar]
  28. NisarH. SaleemO. SapnaF.N.U. A narrative review on the monkeypox virus: An ongoing global outbreak hitting the non-endemic countries.Cureus2023158e4332210.7759/cureus.43322 37700987
     [Google Scholar]
  29. Al-MusaA. ChouJ. LaBereB. The resurgence of a neglected orthopoxvirus: Immunologic and clinical aspects of monkeypox virus infections over the past six decades.Clin. Immunol.202224310910810.1016/j.clim.2022.109108 36067982
     [Google Scholar]
  30. SaiedA.A. DhawanM. MetwallyA.A. FahrniM.L. ChoudharyP. ChoudharyO.P. Disease history, pathogenesis, diagnostics, and therapeutics for human monkeypox disease: A comprehensive review.Vaccines20221012209110.3390/vaccines10122091 36560502
     [Google Scholar]
  31. IslamM.A. HemoM.K. ChopraH. AminM.R. BhattacharyaP. DhamaK. Old enemy with a new face: Re-emerging monkeypox disease-an update.J. Pure Appl. Microbiol.202216Suppl. 12972298810.22207/JPAM.16.SPL1.18
     [Google Scholar]
  32. WalA. VishnoiG. GuptaD. SrivastavaP. WalP. RaiA.K. A detailed insight of monkey pox virus infection in adolescent.Int. J. Pharm. Investig.202313221522310.5530/ijpi.13.2.029
     [Google Scholar]
  33. JohriN. KumarD. NagarP. MauryaA. VengatM. JainP. Clinical manifestations of human monkeypox infection and implications for outbreak strategy.Heal Sci Rev2022100055
     [Google Scholar]
  34. SharmaH. PathakR. JainS. Ficus racemosa L: A review on its important medicinal uses, phytochemicals and biological activities.J. Popul. Ther. Clin. Pharmacol.20233017213227
     [Google Scholar]
  35. SahR. MohantyA. SiddiqA. SinghP. AbdelaalA. AlshahraniN.Z. Monkeypox reported in India–South East Asia region: health and economic challenges.In: Lancet Reg Heal Asia.20224
     [Google Scholar]
  36. FarahatR.A. SahR. El-SakkaA.A. Human monkeypox disease (MPX).Infez. Med.2022303372391 36148174
     [Google Scholar]
  37. MoellingK. Viruses: More friends than foes.World Scientific201610.1142/10230
     [Google Scholar]
  38. EverardM. JohnstonP. SantilloD. StaddonC. The role of ecosystems in mitigation and management of Covid-19 and other zoonoses.Environ. Sci. Policy202011171710.1016/j.envsci.2020.05.017 32501392
     [Google Scholar]
  39. FocosiD. NovazziF. BajA. MaggiF. Monkeypox: An international epidemic.Rev. Med. Virol.2022326e239210.1002/rmv.2392 36029181
     [Google Scholar]
  40. SimS. ChoM. Convergence model of AI and IoT for virus disease control system.Pers. Ubiquitous Comput.20232731209121910.1007/s00779‑021‑01577‑6 34121979
     [Google Scholar]
  41. QudusM.S. CuiX. TianM. The prospective outcome of the monkeypox outbreak in 2022 and characterization of monkeypox disease immunobiology.Front. Cell. Infect. Microbiol.202313119669910.3389/fcimb.2023.1196699 37533932
     [Google Scholar]
  42. MaqboolK.U. ArshH. KumarD. Cardiovascular manifestations of human monkeypox virus: An updated review.Curr. Probl. Cardiol.2023481010186910.1016/j.cpcardiol.2023.101869 37302648
     [Google Scholar]
  43. MarlynJ. BalramR. FarahZ. Mpox (Monkeypox).Treasure Island (FL)StatPearls Publishing2023
     [Google Scholar]
  44. IslamM.A. AhammedT. NoorS.T.A. An estimation of five-decade long monkeypox case fatality rate: Systematic review and meta-analysis.J. Pure Appl. Microbiol.202216Suppl. 13036304710.22207/JPAM.16.SPL1.16
     [Google Scholar]
  45. FerdousJ. BarekM.A. HossenM.S. BhowmikK.K. IslamM.S. A review on monkeypox virus outbreak: New challenge for world.Health Sci. Rep.202361e100710.1002/hsr2.1007 36582623
     [Google Scholar]
  46. AwotonaA. Nigerian government participation in housing: 1970–1980.Habitat Int.1990141174010.1016/0197‑3975(90)90015‑S
     [Google Scholar]
  47. DitekemenaJ.D. NkambaD.M. MutwadiA. COVID-19 vaccine acceptance in the Democratic Republic of Congo: A cross-sectional survey.Vaccines20219215310.3390/vaccines9020153 33672938
     [Google Scholar]
  48. RumunuJ. WamalaJ.F. KongaS.B. Integrated disease surveillance and response in humanitarian context: South Sudan experience.Pan Afr. Med. J.202242Suppl. 113
     [Google Scholar]
  49. ArnetzJ.E. ArbleE. SudanS. ArnetzB.B. Workplace cognitive failure among nurses during the COVID-19 pandemic.Int. J. Environ. Res. Public Health202118191039410.3390/ijerph181910394 34639695
     [Google Scholar]
  50. ProfileC. Democratic Republic of the Congo.Prevalence (all cases/100 000 pop)19862647
     [Google Scholar]
  51. AmooE.O. AdekeyeO. Olawole-IsaacA. Nigeria and Italy divergences in coronavirus experience: Impact of population density.ScientWorldJ202020201910.1155/2020/8923036 32528234
     [Google Scholar]
  52. UrsúaJ.F. WernerA. Rare macroeconomic disasters and lost decades in Latin America: The COVID-19 experience in a historical context.Peterson Institute for International Economics Working Paper2023237
     [Google Scholar]
  53. SklenovskáN. Van RanstM. Emergence of monkeypox as the most important orthopoxvirus infection in humans.Front. Public Health2018624110.3389/fpubh.2018.00241 30234087
     [Google Scholar]
  54. CoghlanB. NgoyP. MulumbaF. Update on mortality in the Democratic Republic of Congo: Results from a third nationwide survey.Disaster Med. Public Health Prep.200932889610.1097/DMP.0b013e3181a6e952 19491603
     [Google Scholar]
  55. RasizadehR. ShamekhA. Shiri AghbashP. Bannazadeh BaghiH. Comparison of human monkeypox, chickenpox and smallpox: A comprehensive review of pathology and dermatological manifestations.Curr. Med. Res. Opin.202339575176010.1080/03007995.2023.2200122 37025009
     [Google Scholar]
  56. SuzukiT. SaitoS. TsuzukiS. Protocol of Tecopox study: A multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox.BMJ Open2023138e06955010.1136/bmjopen‑2022‑069550 37527886
     [Google Scholar]
  57. LiuS. ChuH. Parents’ COVID-19, HPV, and Monkeypox vaccination intention: A multilevel structural equation model of risk, benefit, barrier, and efficacy perceptions and individual characteristics.Patient Educ. Couns.202311410784210.1016/j.pec.2023.107842 37301013
     [Google Scholar]
  58. DjuicyD.D. Sadeuh-MbaS.A. BiloungaC.N. Concurrent Clade I and Clade II monkeypox virus circulation, cameroon, 1979–2022.Emerg. Infect. Dis.202430343244310.3201/eid3003.230861 38325363
     [Google Scholar]
  59. India confirms first case of monkeypox in WHO South-East Asia Region.Available from: https://www.who.int/southeastasia/news/detail/15-07-2022-india-confirms-first-case-of-monkeypox-in-who-south-east-asia-region [cited 2024 Mar 27].
  60. SharmaH. KaushikM. GoswamiP. Role of miRNAs in Brain Development.Microrna202410.2174/0122115366287127240322054519
     [Google Scholar]
  61. HalagaliP. InamdarA. SinghJ. Phytochemicals, herbal extracts, and dietary supplements for metabolic disease management.Endocr. Metab. Immune Disord. Drug Targets20242410.2174/0118715303287911240409055710 38676520
     [Google Scholar]
  62. PhillipsR StarrM OrchardD PurvisD. with it yourself, but you can organise appropriate follow-up.Textb Paediatr Emerg Med2023407
     [Google Scholar]
  63. TranB.X. Anh DoL. HoangT.P. Crucial choices in a global health crisis: Revealing the demand and willingness to pay for a hypothetical monkeypox vaccine the PREVENT study.J. Glob. Health2023130403310.7189/jogh.13.04033 37144922
     [Google Scholar]
  64. BagdeH. DhopteA. BukharyF. Monkeypox and oral lesions associated with its occurrence: A systematic review and meta-analysis.F1000 Res.20231296410.12688/f1000research.137363.1
     [Google Scholar]
  65. ZhouY. ChenZ. Mpox: A review of laboratory detection techniques.Arch. Virol.2023168822110.1007/s00705‑023‑05848‑w 37543543
     [Google Scholar]
  66. WertenauerC. PfeiferC. RoskosM. MärzW. Rapid antigen tests for SARS-CoV-2—a synopsis of the medical evidence.Diagn. Microbiol. Infect. Dis.2023107211602710.1016/j.diagmicrobio.2023.116027 37516068
     [Google Scholar]
  67. ChattopadhyayA. JailaniA.A.K. MandalB. Exigency of plant-based vaccine against COVID-19 emergence as pandemic preparedness.Vaccines2023118134710.3390/vaccines11081347 37631915
     [Google Scholar]
  68. SilvaS.J.R. KohlA. PenaL. PardeeK. Clinical and laboratory diagnosis of monkeypox (mpox): Current status and future directions.iScience202326610675910.1016/j.isci.2023.106759 37206155
     [Google Scholar]
  69. AhsanMM AliMS HassanMM Monkeypox diagnosis with interpretable deep learning.IEEE Access202311819658010.1109/ACCESS.2023.3300793
     [Google Scholar]
  70. NakhriryM.A. Evaluating monkeypox transmission dynamics: Implications for public health interventions.Eig Rev Sci Technol2023717184
     [Google Scholar]
  71. OrganizationW.H. Considerations for the control and elimination of mpox in the WHO European Region update 25 April 2023: the need for integrated national operational plans World Health Organization.Regional Office for Europe2023
     [Google Scholar]
  72. GuptaA. BhagatM. JainV. Blockchain-enabled healthcare monitoring system for early Monkeypox detection.J. Supercomput.20237914156751569910.1007/s11227‑023‑05288‑y 37359326
     [Google Scholar]
  73. CabanillasB. MurdacaG. GuemariA. A compilation answering 50 questions on monkeypox virus and the current monkeypox outbreak.Allergy202378363966210.1111/all.15633 36587287
     [Google Scholar]
  74. PetreI. BarnaF. GurgusD. TomescuL.C. ApostolA. PetreI. Analysis of the Healthcare System in Romania: A Brief Review.Healthcare. MDPI20232069
     [Google Scholar]
  75. SwedS. BohsasH. PatwaryM.M. Knowledge of mpox and its determinants among the healthcare personnel in Arabic regions: A multi-country cross-sectional study.New Microbes New Infect.20235410114610.1016/j.nmni.2023.101146 37363720
     [Google Scholar]
  76. AnwarF. HaiderF. KhanS. Clinical manifestation, transmission, pathogenesis, and diagnosis of monkeypox virus: A comprehensive review.Life202313252210.3390/life13020522 36836879
     [Google Scholar]
  77. DsouzaV.S. RajkhowaP. MallyaB.R. A sentiment and content analysis of tweets on monkeypox stigma among the LGBTQ+ community: A cue to risk communication plan.Dialogues in Health2023210009510.1016/j.dialog.2022.100095 36573228
     [Google Scholar]
  78. AultK. Infectious Diseases in Obstetrics and Gynecology, An Issue of Obstetrics and Gynecology Clinics, E-Book.Elsevier Health Sciences202350
     [Google Scholar]
  79. RonyM.K.K. SharmiP.D. AlamgirH.M. Addressing antimicrobial resistance in low and middle-income countries: Overcoming challenges and implementing effective strategies.Environ. Sci. Pollut. Res. Int.2023304510189610190210.1007/s11356‑023‑29434‑4 37610548
     [Google Scholar]
  80. ThompsonC.A. Dafu-O’ReillyA. WillisT. “Smart” BLE wearables for digital contact tracing in care homes during the COVID-19 Pandemic: A process evaluation of the contact feasibility study.Implement. Sci. Commun.20234115510.1186/s43058‑023‑00533‑0
     [Google Scholar]
  81. Morejón-LlamasN. CristòfolF.J. Monkeypox, disinformation, and fact-checking: A review of ten iberoamerican countries in the context of public health emergency.Information202314739010.3390/info14070390
     [Google Scholar]
  82. TasneemN. Atiqul HaqS.M. AhmedM.N.Q. AhmedK.J. Fertility decisions in the wake of COVID-19: A comprehensive review of influencing determinants and trends.SN Soc. Sci.20233813510.1007/s43545‑023‑00729‑0
     [Google Scholar]
  83. HymanP. The disappearance of the primary care physical examination—losing touch.JAMA Intern. Med.2020180111417141810.1001/jamainternmed.2020.3546 32832987
     [Google Scholar]
  84. BrainardJ. HunterP.R. Misinformation making a disease outbreak worse: outcomes compared for influenza, monkeypox, and norovirus.Simulation202096436537410.1177/0037549719885021 34285423
     [Google Scholar]
  85. MaruV. GhaffarU. RawatA. Clinical and epidemiological interventions for monkeypox management in children: A systematic review.Cureus2023155e3852110.7759/cureus.38521 37288174
     [Google Scholar]
  86. AshiqueS. PalR. SharmaH. MishraN. GargA. Unraveling the emerging niche role of extracellular vesicles (EVs) in traumatic brain injury (TBI).CNS Neurol. Disord. Drug Targets20242310.2174/0118715273288155240201065041 38351688
     [Google Scholar]
  87. BhatS. SahaS. GargT. SehrawatH. ChopadeB.A. GuptaV. Insights into the challenging multi-country outbreak of Mpox: A comprehensive review.J. Med. Microbiol.2023726172510.1099/jmm.0.001725 37378642
     [Google Scholar]
  88. ChaberA.L. MoloneyG.K. RenaultV. Examining the international bushmeat traffic in Belgium: A threat to conservation and public health.One Heal2023100605
     [Google Scholar]
  89. HassanO.A. de BaloghK. WinklerA.S. One Health early warning and response system for zoonotic diseases outbreaks: Emphasis on the involvement of grassroots actors.Vet. Med. Sci.2023941881188910.1002/vms3.1135 37322837
     [Google Scholar]
  90. MphandeF.A. Preparedness and Response: Outlook Post COVID-19 Pandemic and SDG3d.Sustainable Health in Low and Middle Income Countries: Achieving SDG3 in the (Post) Pandemic World.Springer2023618010.1007/978‑981‑99‑4254‑1_4
     [Google Scholar]
  91. BardhanM. RayI. RoyS. Emerging zoonotic diseases and COVID-19 pandemic: global Perspective and Indian Scenario.Ann. Med. Surg.20238583997400410.1097/MS9.0000000000001057 37554903
     [Google Scholar]
  92. Centers for Disease Control and Prevention (CDC)Ten great public health achievements: United States, 1900-1999.MMWR Morb. Mortal. Wkly. Rep.19994812241243 10220250
     [Google Scholar]
  93. KhanM.R. HossainM.J. RoyA. IslamM.R. Decreasing trend of monkeypox cases in Europe and America shows hope for the world: Evidence from the latest epidemiological data.Health Sci. Rep.202361e1030
     [Google Scholar]
  94. GuptaA.K. TalukderM. RosenT. PiguetV. Differential diagnosis, prevention, and treatment of mpox (Monkeypox): A review for dermatologists.Am. J. Clin. Dermatol.202324454155610.1007/s40257‑023‑00778‑4 37106278
     [Google Scholar]
  95. DasS. MukherjeeT. MohantyS. Impact of NF-κB signaling and sirtuin-1 protein for targeted inflammatory intervention.Curr. Pharm. Biotechnol.20242510.2174/0113892010301469240409082212 38638042
     [Google Scholar]
  96. AmicosanteA.M.V. RossoA. BernardiniF. COVID-19 contact tracing strategies during the first wave of the pandemic: Systematic review of published studies.JMIR Public Health Surveill.202391e4267810.2196/42678 37351939
     [Google Scholar]
  97. EmimiM. KhaleelM. AlkrashA. The current opportunities and challenges in drone technology.Int J Electr Eng Sustain20237489
     [Google Scholar]
  98. WoutersO.J. FormanR. AndersonM. MossialosE. McKeeM. The launch of the EU Health Emergency and Preparedness and Response Authority (HERA): improving global pandemic preparedness?New YorkHealth Policy2023104844
     [Google Scholar]
  99. SelvarajN. ShyamS. DhurairajP. Mpox: epidemiology, clinical manifestations and recent developments in treatment and prevention.Expert Rev. Anti Infect. Ther.202321664165310.1080/14787210.2023.2208346 37101419
     [Google Scholar]
  100. ShafaatiM. ZandiM. Human monkeypox (hMPXV) re‐emergence: Host immunity status and current vaccines landscape.J. Med. Virol.2023951e2825110.1002/jmv.28251 36271768
     [Google Scholar]
  101. KandeelM. MorsyM.A. Abd El-LateefH.M. Efficacy of the modified vaccinia Ankara virus vaccine and the replication-competent vaccine ACAM2000 in monkeypox prevention.Int. Immunopharmacol.202311911020610.1016/j.intimp.2023.110206 37087871
     [Google Scholar]
  102. ShulmanS.T. Monkeypox emergence and the eradication of smallpox: An historical review.J. Pediatric Infect. Dis. Soc.2023122737510.1093/jpids/piac120 36409569
     [Google Scholar]
  103. GhoshN. ChackoL. VallamkonduJ. Clinical strategies and therapeutics for human monkeypox virus: A revised perspective on recent outbreaks.Viruses2023157153310.3390/v15071533 37515218
     [Google Scholar]
  104. SharmaH. PathakR. KumarN. Endocannabinoid system: Role in depression, recompense, and pain control.J Surv Fish Sci2023104S27432751
     [Google Scholar]
  105. AminizadehS. HeidariA. ToumajS. The applications of machine learning techniques in medical data processing based on distributed computing and the Internet of Things.Comput. Methods Programs Biomed.202324110774510.1016/j.cmpb.2023.107745 37579550
     [Google Scholar]
  106. MayT. TowlerL. SmithL.E. Mpox knowledge, behaviours and barriers to public health measures among gay, bisexual and other men who have sex with men in the UK: A qualitative study to inform public health guidance and messaging.medRxiv202310.1101/2023.05.19.23290102
     [Google Scholar]
  107. MphandeF.A. Priority diseases, sustained response and SDG3. 3.Sustainable health in low and middle income countries: Achieving SDG3 in the (Post) pandemic world.Springer2023296010.1007/978‑981‑99‑4254‑1_3
     [Google Scholar]
  108. DubeyR.S. KalyanS. PathakB. Impacts of urbanization and climate change on habitat destruction and emergence of zoonotic species.Climate change and urban environment sustainability.Springer202330332210.1007/978‑981‑19‑7618‑6_17
     [Google Scholar]
  109. Pathak, Rashmi & Sharma, Himanshu & Nogai, Lipi & Bhandari, Maulshree & Koli, Manju & Mishra, Riya & Kumar N. A brief review on pathogenesis, transmission and management of monkeypox virus outbreaks.Bull Environ Pharmacol Life Sci2023124244256
     [Google Scholar]
  110. WaheedY. SahR. MuhammadK. Recent developments in vaccines for viral diseases.Vaccines202311219810.3390/vaccines11020198 36851076
     [Google Scholar]
  111. UpadhayayS ArthurR SoniD Monkeypox infection: The past, present, and future.Int Immunopharmacol2022113Pt A10938210.1016/j.intimp.2022.10938236330915
     [Google Scholar]
  112. ChakrabortyS. MohapatraR.K. ChandranD. Monkeypox vaccines and vaccination strategies: Current knowledge and advances. An update: Correspondence.Int. J. Surg.202210510686910.1016/j.ijsu.2022.106869 36049620
     [Google Scholar]
/content/journals/covid/10.2174/0126667975301557240604113752
Loading
A Review on Mpox: Diagnosis, Prevention and Treatments
Coronaviruses 6, E130624231013 (2025); https://doi.org/10.2174/0126667975301557240604113752
/content/journals/covid/10.2174/0126667975301557240604113752
/content/journals/covid/10.2174/0126667975301557240604113752
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): clinical; global health vaccines; Mpox; public health; surveillance; therapeutic interventions; zoonotic threat

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test